Chai Ning, Liu Jian-Feng, Xue Yan-Xue, Yang Chang, Yan Wei, Wang Hui-Min, Luo Yi-Xiao, Shi Hai-Shui, Wang Ji-Shi, Bao Yan-Ping, Meng Shi-Qiu, Ding Zeng-Bo, Wang Xue-Yi, Lu Lin
1] Peking University Sixth Hospital/Institute of Mental Health and Key Laboratory of Mental Health, Ministry of Health, Beijing, China [2] Institute of Mental Health and Hebei Brain Ageing and Cognitive Neuroscience Laboratory, Hebei Medical University, Shijiazhuang, China.
1] Peking University Sixth Hospital/Institute of Mental Health and Key Laboratory of Mental Health, Ministry of Health, Beijing, China [2] National Institute on Drug Dependence, Peking University, Beijing, China.
Neuropsychopharmacology. 2014 Jul;39(8):1933-45. doi: 10.1038/npp.2014.42. Epub 2014 Feb 19.
Fear extinction has been extensively studied, but little is known about the molecular processes that underlie the persistence of extinction long-term memory (LTM). We found that microinfusion of norepinephrine (NE) into the CA1 area of the dorsal hippocampus during the early phase (0 h) after extinction enhanced extinction LTM at 2 and 14 days after extinction. Intra-CA1 infusion of NE during the late phase (12 h) after extinction selectively promoted extinction LTM at 14 days after extinction that was blocked by the β-receptor antagonist propranolol, protein kinase A (PKA) inhibitor Rp-cAMPS, and protein synthesis inhibitors anisomycin and emetine. The phosphorylation levels of PKA, cyclic adenosine monophosphate response element-binding protein (CREB), GluR1, and the membrane GluR1 level were increased by NE during the late phase after extinction that was also blocked by propranolol and Rp-cAMPS. These results suggest that the enhancement of extinction LTM persistence induced by NE requires the activation of the β-receptor/PKA/CREB signaling pathway and membrane GluR1 trafficking. Moreover, extinction increased the phosphorylation levels of Erk1/2, CREB, and GluR1, and the membrane GluR1 level during the late phase, and anisomycin/emetine alone disrupted the persistence of extinction LTM, indicating that the persistence of extinction LTM requires late-phase protein synthesis in the CA1. Propranolol and Rp-cAMPS did not completely disrupt the persistence of extinction LTM, suggesting that another β-receptor/PKA-independent mechanism underlies the persistence of extinction LTM. Altogether, our results showed that enhancing hippocampal noradrenergic activity during the late phase after extinction selectively promotes the persistence of extinction LTM.
恐惧消退已得到广泛研究,但对于消退长期记忆(LTM)持久性背后的分子过程却知之甚少。我们发现,在消退后的早期阶段(0小时)向背侧海马体的CA1区微量注射去甲肾上腺素(NE),可增强消退后2天和14天的消退LTM。在消退后的晚期阶段(12小时)向CA1区内注射NE,可选择性地促进消退后14天的消退LTM,而β受体拮抗剂普萘洛尔、蛋白激酶A(PKA)抑制剂Rp-cAMPS以及蛋白质合成抑制剂茴香霉素和放线菌酮可阻断这一作用。在消退后的晚期阶段,NE可增加PKA、环磷酸腺苷反应元件结合蛋白(CREB)、GluR1的磷酸化水平以及膜GluR1水平,而普萘洛尔和Rp-cAMPS也可阻断这一作用。这些结果表明,NE诱导的消退LTM持久性增强需要激活β受体/PKA/CREB信号通路以及膜GluR1转运。此外,消退在晚期阶段增加了Erk1/2、CREB和GluR1的磷酸化水平以及膜GluR1水平,单独使用茴香霉素/放线菌酮会破坏消退LTM的持久性,这表明消退LTM的持久性需要CA1区晚期阶段的蛋白质合成。普萘洛尔和Rp-cAMPS并未完全破坏消退LTM的持久性,这表明另一种不依赖β受体/PKA的机制是消退LTM持久性的基础。总之,我们的结果表明,在消退后的晚期阶段增强海马体去甲肾上腺素能活性可选择性地促进消退LTM的持久性。